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Conclusion - In patients with lone AF treated with rate or rhythm control, cardiovascular
event rate was low, compared to patients with UHD. QoL is higher in patients with lone
AF. Event rate with lone AF was too small to assess whether to prefer rate or rhythm con-
trol.
1166-218 Modification of Electrophysiologic Properties of 
Pulmonary Veins and Adjacent Left Atrial Tissue by 
Radiofrequency Circumferential Ablation of the 
Pulmonary Vein Ostia: Correlation With Nonrecurrence 
of Atrial Fibrillation
Hiroshi Sohara, Shyutaro Satake, Kazushi Tanaka, Sugako Ishigaki, Yoshio Yamaguchi, 
Shigeru Saito, Yoshio Watanabe, Shonan Kamakura General Hospital, kamakura, Japan
Background: Electrical disconnection between pulmonary veins (PVs) and left atrium
(LA) is now frequently used in the treatment paroxysmal atrial fibrillation (AF). Ablation of
PVs per se is, however, time consuming and is often complicated with PV stenosis. Fur-
thermore, the rate of recurrence is rather high perhaps due to anatomical variations of
PV-LA junctional area. Hence, we tested the efficacy of PV ostial ablation with a novel
radio-frequency balloon catheter (RBC) and elucidated the electrophysiologic changes
required for the maintenace of sinus rhythm.
Methods and Results: Forty-nine patients with drug-resistant AF underwent circumferen-
tial ablation of PV-LA junction by RBC. Post ablation changes in electrophysiologic prop-
erties around the PV ostia were studied with a basket catheter and were correlated with
AF recurrence in 34 early cases (ablating 68 superior PVs) and 15 later cases (53 supe-
rior and inferior PVs). Total elimination of PV potentials or PV-LA dissociation was
achieved in 92.7% (63/68 PVs) and 92.5% (49/53 PVs), respectively. During mean follow-
up periods of 15.1+/-4.8 and 6.2+/-2.2 months, AF recurred in 38.2%(13/34cases) and
13.3%(2/15) in early and later groups, but no case developed PV stenosis. Although the
amplitude of PV and periostial LA potentials were decreased (p<0.0001) in all patients,
the remaining PV potentials in 34 nonrecurrence cases were definitely smaller than those
in 15 recurrence cases (p<0.0001). When a cut-off level of less than 0.4 mV in receiver
operating characteristic curves was used, its negative predictive value for non-recurrence
of AF was 93% and specificity was 95.2%.
Conclusions: Circumferential PV ostial ablation with an RBC is highly effective in termi-
nating AF without the risk of PV stenosis. Maintenance of sinus rhythm can be predicted
when both supeior and inferior PVs are ablated and amplitudes of all the remaining PV-
LA potentials are decreased to less than 0.4mV.
POSTER SESSION
1167 
Effects of Cardiac Pacing and 
Resynchronization Therapy
Tuesday, March 09, 2004, 3:00 p.m.-5:00 p.m.
Morial Convention Center, Hall G
Presentation Hour: 4:00 p.m.-5:00 p.m.
1167-207 Improved Response Rate and Left Ventricular Epicardial 
Lead Stability Following Robotically-Assisted 
Ventricular Resynchronization
Sandhya K. Balaram, Robert C. Ashton, Jr., Jonathan S. Steinberg, Daniel G. Swistel, 
Frederick Ehlert, Margot E. Vloka, Joseph J. DeRose, Jr., St. Luke's-Roosevelt Hospital 
Center, Columbia University College of Physicians and Surgeons, New York, NY
Background: Robotically-assisted left ventricular (LV) epicardial lead implantation is a
safe and effective technique for biventricular pacing. We hypothesized that such a strat-
egy for ventricular resynchronization therapy might produce improved clinical response
rates over the medium term.
Methods: Twenty patients with congestive heart failure (NYHA Class 3.5 ± 0.5) and a
widened QRS (184 ± 30 msec) underwent robotic LV lead placement for biventricular
pacing. Mean patient age was 69.4 ± 11.6 years, LV ejection fraction (EF) was 12.3 ± 6%
and left ventricular end diastolic volume was 6.8 ± 1.2 cm. The etiology of heart failure
was ischemic in 55% and idiopathic in 45%. Ten patients (50%) had prior coronary artery
bypass surgery. Indications for robotic LV lead implant included failure of coronary sinus
cannulation (10), atretic venous tributaries (4), poor LV lead capture (3), primary implant
(2) and coronary sinus dissection (1).
Results: Two epicardial leads were placed on the posterolateral surface of the LV in all
patients as directed by intra-operative electrophysiologic mapping. Implant success rate
was 100%. Intraoperative lead threshold was 1.2 ± 0.6 v at 0.5 ms, R-wave was 14.4 ±
8.7 mv, and impedance was 1098 ± 220 ohms at 0.5 v. Complications included one post-
operative pneumonia, one intraoperative LV injury and one episode of post-operative
renal insufficiency. At an average follow-up of 8.5 ± 4.4 months, 19 of 20 patients are
alive and well. Improvements in exercise tolerance have been demonstrated in 85% of
patients and there have been no lead failures over the follow-up period. Statistically sig-
nificant improvements in ejection fraction (19.9 ± 13%, p=0.03) and QRS duration (149 ±
21 msec, p=0.007) have also been measured. Over the medium-term lead thresholds
have remained unchanged (1.8 ± 1.1V at 0.5 ms, p=ns), and a significant drop in imped-
ance (310 ± 54 ohms, p=0.005) has been detected.
Conclusions: Robotic LV epicardial leads remain stable and reliable over the medium
term. Improved clinical response rates may be achieved with the site directed implanta-
tion strategy that this technique affords.
1167-208 Relationship Between QRS Duration and Left 
Ventricular Dyssynchrony in Patients With End Stage 
Heart Failure
G. B. Bleeker, M. J. Schalij, S. G. Molhoek, H. F. Verwey, E. E. van der Wall, J. J. Bax, 
Leiden University Medical Center, Leiden, The Netherlands
Background: Patients with end-stage heart failure and wide QRS complex are consid-
ered candidates for cardiac resynchronization therapy (CRT). A wide QRS complex is
considered to represent left ventricular (LV) dyssynchrony. However, 20-30% of these
patients do not respond to CRT. Tissue Doppler Imaging (TDI) may provide more accu-
rate information on intra-LV dyssynchrony. Accordingly we evaluated a large cohort of
patients with different QRS durations with TDI to assess LV dyssynchrony.
Methods: 90 consecutive patients with severe heart failure (LVEF<35%, NYHA class III-
IV) were divided into 3 groups of 30 patients based on QRS duration. (<120ms, 120-150
ms and > 150ms). All patients underwent TDI to assess LV dyssynchrony and QRS dura-
tion was compared to the septal-to-lateral delay (S-L delay), a direct marker of LV dys-
synchrony. Based on previous work, an S-L delay >60 ms was considered indicative of
severe LV dyssynchrony.
Results: Severe dyssynchrony was observed in 8 patients (27%) with narrow QRS com-
plex (<120 ms), in 18 patients (60%) with a QRS duration of 120-150 ms, and in 21
patients (70%) with QRS > 150 ms (see figure). No relation existed between QRS dura-
tion and S-L delay.
Conclusions: QRS duration does not adequately reflect intra LV dyssynchrony and TDI
should be used alternatively. In addition, 27% of patients with heart failure and narrow
QRS complex have dyssynchrony and may be candidates for CRT.
1167-219 Long-Term Reliability of Epicardial and Transvenous 
Leads Used for Cardiac Resynchronization Therapy
John D. Hummel, Leslie A. Saxon, Jerry Luck, David Meyer, Patrick Yong, The VIGOR 
CHF/VENTAK CHF CONTAK CD Study Investigators, Riverside Methodist Hospital, 
Columbus, OH, Guidant Corporation, St. Paul, MN
Background: Left ventricular pacing leads used in cardiac resynchronization therapy are
either placed in the coronary venous vasculature transvenously (TRANS) or surgically
implanted transthoracically on the epicardium (EPI) via limited thoracotomy. A long-term
comparison of the reliability of these leads in heart failure patients (pts) has not been pre-
viously discussed.
Methods: Pts participating in the VIGOR CHF and VENTAK CHF/CONTAK CD studies
had either TRANS (443 pts) or EPI (109 pts) leads implanted. EPI leads were either ste-
roid eluting sutureable (SUT, 81 pts) or non-steroid eluting screw-in myocardial (MYO, 28
pts). A Kaplan-Meier estimate of the time to lead failure or replacement was calculated
for TRANS vs. EPI as well as for SUT vs. MYO leads. Pt deaths and explants due to heart
transplant or infection were censored at the time of the event.
Results: Revision was required in 44 TRANS (10%) and 26 EPI (24%) leads [9 MYO
(32%) and 17 SUT (21%)]. Failure in TRANS leads was typically due to dislodgment
while that of EPI leads was usually due to exit block or lead fracture. TRANS leads were
significantly more reliable than EPI (hazard ratio=2.5, p=0.0003). SUT trended to greater
reliability than MYO (hazard ratio=2.1, p=0.08).
Incidence of the primary endpoint and its components
Lone AF AF with UHD
Rate control 
(n=53)
Rhythm 
control (n=55)
Rate control 
(n=203)
Rhythm control 
(n=211)
Endpoint - no.(%) 7 (13) 3 (5) 37 (18) 57 (27)
Cardiovascular 
mortality
2 (4) 1 (2) 16 (8) 17 (8)
Heart failure 0 0 9 (4) 12 (6)
Thromboembolic 
complications
2 (4) 1 (2) 12 (6) 20 (9)
Bleeding 4 (8) 1 (2) 8 (4) 8 (4)
Side effects of 
antiarrhythmic drugs
0 0 2 (1) 12 (6)
Pacemaker implants 1 (2) 1 (2) 2 (1) 7 (3)
